Product Code: GVR-2-68038-930-2
Skin Antiseptic Product Market Growth & Trends:
The global skin antiseptic product market size is expected to reach USD 478.35 million by 2030, registering a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Rising incidences of Hospital-Acquired Infections (HAIs) and increasing usage of surgical units and endoscope reprocesses are the key driving factors for the market. The rising number of surgeries being performed is also expected to drive the market during the forecast period. According to the Agency for Healthcare Research and Quality (AHRQ), 17.2 million hospital visits included surgical procedures in the U.S. in 2014.
Demand for alcohol antiseptics for pre-injection and pre-operative skin preparations is increasing significantly. In addition, alcohol antiseptics are being used as a base along with various formulations, such as iodine and chlorhexidine. Exceptional properties of alcohol-based antiseptics for surgical purposes are driving the market. Growing awareness regarding the benefits of skin antiseptic products and increasing R&D funding are creating opportunities for market entrants. Moreover, various programs being conducted by manufacturers and governments to boost the awareness about the importance of using skin antiseptic products are also expected to contribute significantly to the skin antiseptic product market growth.
Skin Antiseptic Product Market Report Highlights:
- North America led the global market in 2018 and is anticipated to maintain its position throughout the forecast years, owing to a rise in the number of surgeries being performed and the presence of key companies in the region
- Octenidine is anticipated to be the fastest-growing formulation segment during the forecast period. Octenidine is an internal substitute for chlorhexidine and iodine
- The injection segment led the market in 2018 owing to a rise in the incidence of spinal injuries and usage of skin antiseptic products for pre-injection skin preparation
- The wipes segment is expected to witness the fastest growth during the forecast period, as wipes are easy to use and possess a lesser risk of contamination
- Key companies in the skin antiseptic product market are BD, 3M, Ecolab, Schulke & Mayr GmbH, Sage Products LLC, Johnson & Johnson, and B. Braun Melsungen AG
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.2 Volume Price Analysis (Model 2)
- 1.7 List of Secondary Sources
- 1.8 Objectives
- 1.8.1 Objective 1: Understanding Market Dynamics In The Given Countries.
- 1.8.2 Objective 2: Understanding Market Estimates And Forecasts
- 1.8.3 Objective 3: Understanding Attributes To Provide Elaborate Details On The Market Structure & Strategic Undertakings & Their Impact.
- 1.8.4 Objective 4: Understanding Key Formulations, Type, And Application Scopes To Conclude On The Market Size.
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Skin Antiseptic Products Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Product Pipeline Analysis
- 3.4 User Perspective Analysis
- 3.4.1 Consumer Behavior Analysis
- 3.4.2 Market Influencer Analysis
- 3.5 List of Key End Users
- 3.6 Regulatory Framework
- 3.7 Market Dynamics
- 3.7.1 Market Driver Analysis
- 3.7.1.1 Increasing Prevalence Of Hospital Acquired Diseases (Hais)
- 3.7.1.2 Increasing Use Of Endoscope Reprocesses And Surgical Units
- 3.7.2 Market Restraint Analysis
- 3.7.2.1 Stringent Regulations Related To The Usage Of Antiseptics & Disinfectants
- 3.7.3 Industry Challenges
- 3.7.3.1 Lack of relevant knowledge in developing countries
- 3.8 Skin Antiseptic Products: Market Analysis Tools
- 3.8.1 Industry Analysis - Porter's Five Forces Analysis
- 3.8.2 Pestle Analysis
- 3.8.2.1 Political & Legal
- 3.8.2.2 Economic
- 3.8.2.3 Technological
- 3.8.3 Major Deals And Strategic Alliances
- 3.8.3.1 Acquisition
- 3.8.3.2 Partnerships
- 3.8.4 Market Entry Strategies
Chapter 4 Skin Antiseptic Products Market: Segment Analysis, By Formulation, 2018 - 2030 (USD Million)
- 4.1 Definition and Scope
- 4.2 Formulation Type Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Skin Antiseptic Products Market, by Formulation, 2018 to 2030
- 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.5.1 Alcohols
- 4.5.1.1 Alcohols Market, 2018 - 2030 (USD Million)
- 4.5.2 Chlorhexidine
- 4.5.2.1 Chlorhexidine Market, 2018 - 2030 (USD Million)
- 4.5.3 Iodine
- 4.5.3.1 Iodine Market, 2018 - 2030 (USD Million)
- 4.5.4 Octenidine
- 4.5.4.1 Octenidine Market, 2018 - 2030 (USD Million)
- 4.5.5 Others
- 4.5.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Skin Antiseptic Products Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 5.1 Definition and Scope
- 5.2 Type Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Skin Antiseptic Products Market, by Type, 2018 to 2030
- 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.5.1 Solutions
- 5.5.1.1 Solutions Market, 2018 - 2030 (USD Million)
- 5.5.2 Swab Sticks
- 5.5.2.1 Swab Sticks Market, 2018 - 2030 (USD Million)
- 5.5.3 Wipes
- 5.5.3.1 Wipes market, 2018 - 2030 (USD Million)
Chapter 6 Skin Antiseptic Products Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 6.1 Definition and Scope
- 6.2 Application Type Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Skin Antiseptic Products Market, by Application, 2018 to 2030
- 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.5.1 Surgeries
- 6.5.1.1 Surgeries Market, 2018 - 2030 (USD Million)
- 6.5.1.2 Spinal Surgery
- 6.5.1.2.1 Spinal Surgery Market, 2018 - 2030 (USD Million)
- 6.5.1.3 Joint Surgery
- 6.5.1.3.1 Joint Surgery Market, 2018 - 2030 (USD Million)
- 6.5.1.4 Other Surgery
- 6.5.1.4.1 Other Surgery Market, 2018 - 2030 (USD Million)
- 6.5.2 Injection
- 6.5.2.1 Injection Market, 2018 - 2030 (USD Million)
- 6.5.2.2 Spinal Injection
- 6.5.2.2.1 Spinal Injection Market, 2018 - 2030 (USD Million)
- 6.5.2.3 Joint Injection
- 6.5.2.3.1 Joint Injection Market, 2018 - 2030 (USD Million)
- 6.5.2.4 Other Injection
- 6.5.2.4.1 Other injection market, 2018 - 2030 (USD Million)
Chapter 7 Skin Antiseptic Products Market: Regional Market Analysis, By Formulation, Type, and Application, 2018 - 2030 (USD Million)
- 7.1 Definition & Scope
- 7.2 Regional Market Share Analysis, 2022 & 2030
- 7.3 Regional Market Dashboard
- 7.4 Regional Market Snapshot
- 7.5 Regional Market Share and Leading Players, 2018
- 7.6 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.6.1 North America
- 7.6.2 Europe
- 7.6.3 Asia Pacific
- 7.6.4 Latin America
- 7.6.5 Middle East And Africa
- 7.7 Market Size, & Forecasts, Volume And Trend Analysis, 2018 To 2026
- 7.8 North America
- 7.8.1 North America Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.8.2 U.S.
- 7.8.2.1 U.S. Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.8.3 Canada
- 7.8.3.1 Canada Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.9 Europe
- 7.9.1 Europe Skin Antiseptic Products Market, By 2018 - 2030 (USD Million)
- 7.9.2 UK
- 7.9.2.1 UK Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.9.3 Germany
- 7.9.3.1 Germany Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.9.4 France
- 7.9.4.1 France Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.9.5 Italy
- 7.9.5.1 Italy Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.9.6 Spain
- 7.9.6.1 Spain Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.10 Asia Pacific
- 7.10.1 Asia Pacific Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.10.2 Japan
- 7.10.2.1 Japan Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.10.3 China
- 7.10.3.1 China Skin Atiseptic Products Market, 2018 - 2030 (USD Million)
- 7.10.4 India
- 7.10.4.1 India Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.10.5 Australia
- 7.10.5.1 Australia skin antiseptic products market, 2018 - 2030 (USD Million)
- 7.10.6 South Korea
- 7.10.6.1 South Korea skin antiseptic products market, 2018 - 2030 (USD Million)
- 7.11 Latin America
- 7.11.1 Latin America Skin Antiseptic Products Market, By Product, 2018 - 2030 (USD Million)
- 7.11.2 Brazil
- 7.11.2.1 Brazil Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.11.3 Mexico
- 7.11.3.1 Mexico Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.11.4 Argentina
- 7.11.4.1 Argentina Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.11.5 Colombia
- 7.11.5.1colombia Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.12 MEA
- 7.12.1 MEA Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.12.2 South Africa
- 7.12.2.1 South Africa Skin Antiseptic Products Market, 2018 - 2030 (USD Million)
- 7.12.3 Saudi Arabia
- 7.12.3.1 Saudi Arabia skin antiseptic products market, 2018 - 2030 (USD Million)
- 7.12.4 UAE
- 7.12.4.1 UAE Skin antiseptic products market, 2018 - 2030 (USD Million)
Chapter 8 Skin Antiseptic Products Market - Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.2 Company Categorization
- 8.3 Vendor Landscape
- 8.3.1 List Of Key Distributors And Channel Partners
- 8.3.2 Key Customers
- 8.3.3 Key Company Market Share Analysis, 2021
- 8.4 Public Companies
- 8.4.1 Company Market Position Analysis
- 8.4.2 Regional Network Map
- 8.5 Supplier Ranking
- 8.6 Company Profiles
- 8.6.1 3M
- 8.6.1.1 Company overview
- 8.6.1.2 Financial performance
- 8.6.1.3 Product benchmarking
- 8.6.1.4 Strategic initiatives
- 8.6.2 ECOLAB
- 8.6.2.1 Company overview
- 8.6.2.2 Financial performance
- 8.6.2.3 Product benchmarking
- 8.6.2.4 Strategic initiatives
- 8.6.3 BD
- 8.6.3.1 Company overview
- 8.6.3.2 Financial performance
- 8.6.3.3 Product benchmarking
- 8.6.3.4 Strategic initiatives
- 8.6.4 SCHULKE & MAYR GMBH
- 8.6.4.1 Company overview
- 8.6.4.2 Financial performance
- 8.6.4.3 Product benchmarking
- 8.6.4.4 Strategic initiatives
- 8.6.5 SAGE PRODUCTS LLC
- 8.6.5.1 Company overview
- 8.6.5.2 Financial performance
- 8.6.5.3 Product benchmarking
- 8.6.5.4 Strategic initiatives
- 8.6.6 B. BRAUN MELSUNGEN AG
- 8.6.6.1 Company overview
- 8.6.6.2 Financial performance
- 8.6.6.3 Product benchmarking
- 8.6.5.4 Strategic initiatives
- 8.6.7 CARDINAL HEALTH
- 8.6.7.1 Company overview
- 8.6.7.2 Financial performance
- 8.6.7.3 Product benchmarking
- 8.6.7.4 Strategic initiatives
- 8.6.8 SMITH & NEPHEW
- 8.6.8.1 Company overview
- 8.6.8.2 Financial performance
- 8.6.8.3 Product benchmarking
- 8.6.8.4 Strategic initiatives
- 8.6.9 AVRIO HEALTH
- 8.6.9.1 Company overview
- 8.6.9.2 Financial performance
- 8.6.9.3 Product benchmarking
- 8.6.9.4 Strategic initiatives
- 8.6.10 MICROGEN
- 8.6.10.1 Company overview
- 8.6.10.2 Financial performance
- 8.6.10.3 Product benchmarking
- 8.6.10.3 Strategic initiatives